TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial
First Cohort B patient received 4 doses (approx. 819 million Gamma Delta T-cells)Cohort B recruitment continues at multiple clinical sites across the United Kingdom
